AP News·5 min read·medium

FDA reviews BPC-157, TB-500 and other peptides favored by RFK Jr.

M
Matthew Perrone
FDA reviews BPC-157, TB-500 and other peptides favored by RFK Jr.
AI Summary

The FDA is convening a panel to review the safety and efficacy of peptides, which have gained popularity as wellness supplements despite a lack of clinical evidence. The review is politically charged due to support from Health Secretary Robert F. Kennedy Jr. and various wellness influencers.

Add AP News as your preferred source to see more of our stories on Google. --> Share

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthpoliticsscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in